These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 14149342)

  • 1. [CORRECTION BY ETYBENZATROPINE OF EXTRAPYRAMIDAL SYMPTOMS DUE TO NEUROLEPTICS].
    BORENSTEIN P; BLES G
    Presse Med (1893); 1964 May; 72():1595-6. PubMed ID: 14149342
    [No Abstract]   [Full Text] [Related]  

  • 2. [SOME REMARKS ON THE INDICATIONS FOR UK-738 (PONALIDE) AS A CORRECTOR OF EXTRAPYRAMIDAL DISORDERS DUE TO NEUROLEPTICS].
    BORENSTEIN P; BLES G
    Gaz Med Fr; 1964 May; 71():2075. PubMed ID: 14144655
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of drug-induced extrapyramidal symptoms. (A comparative study of three antiparkinson agents).
    KRUSE W
    Dis Nerv Syst; 1960 Feb; 21():79-81. PubMed ID: 14412284
    [No Abstract]   [Full Text] [Related]  

  • 4. [Contribution to the study of extrapyramidal syndromes following use of neuroleptics. Apropos of the use of 2 psychotropic substances with powerful neurotropic activity].
    BORENSTEIN P; DABBAH M; BLES G
    Ann Med Psychol (Paris); 1962 Mar; 120(1)():506-52 concl. PubMed ID: 13871265
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oxygen in the therapy of extrapyramidal syndromes induced by neuroleptics. Practical and theoretical importance].
    DEMBER HC; FLORIO D
    Ann Med Psychol (Paris); 1962 Apr; 120(1)():759-65. PubMed ID: 13885297
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE INFLUENCE OF ACTION OF ANTINEUROLEPTIC DRUGS ON THE NEUROLEPTIC THRESHOLD].
    HAASE HJ; ZAHN M; ZSCHUCKE CF
    Int J Neuropsychiatry; 1965; 1():239-52. PubMed ID: 14309089
    [No Abstract]   [Full Text] [Related]  

  • 7. [PARALYSIS OF ACCOMMODATION DURING A TREATMENT BY A CORRECTOR OF EXTRAPYRAMIDAL DISORDERS INDUCED BY NEUROLEPTICS].
    BONNET ; LEOPOLD ; ISTRE
    Bull Soc Ophtalmol Fr; 1964 Apr; 64():433-6. PubMed ID: 14295582
    [No Abstract]   [Full Text] [Related]  

  • 8. THE SIDE-EFFECTS OF NEUROLEPTICS AS A SOURCE OF DIAGNOSTIC ERRORS.
    HOFF H
    Encephale; 1964; 53():SUPPL:165-9. PubMed ID: 14161528
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new controlling agent of extrapyramidal syndromes caused by neuroleptics: ethybenzatropine (UK 738)].
    BORENSTEIN P; BLES G; DABBAH M; CROIZE B
    Psychiatr Neurol (Basel); 1963; 145():144-79. PubMed ID: 14013909
    [No Abstract]   [Full Text] [Related]  

  • 10. Relevance of drug-induced extrapyramidal reactions to behavioral changes during neuroleptic treatment. II. Combined treatment with trifluoperazine-amobarbital.
    BRUNE GG; KOBAYASHI T; BULL C; TOURLENTES TT; HIMWICH HE
    Compr Psychiatry; 1962 Oct; 3():292-6. PubMed ID: 13873984
    [No Abstract]   [Full Text] [Related]  

  • 11. Extrapyramidal symptoms of triflupromazine, mepazine, prochlorperazine.
    DARLING HF
    Dis Nerv Syst; 1959 Dec; 20():569-71. PubMed ID: 13814128
    [No Abstract]   [Full Text] [Related]  

  • 12. Extrapyramidal symptoms associated with the administration of trifluoperazine: report of a case treated with diphenhydramine.
    FANNING WJ
    Can Med Assoc J; 1961 Dec; 85(27):1459. PubMed ID: 13891541
    [No Abstract]   [Full Text] [Related]  

  • 13. Extrapyramidal side effects of trifluoperazine.
    MOULTON SE; JOHNSON FP; PRICKMAN LE
    Proc Staff Meet Mayo Clin; 1961 May; 36():268-70. PubMed ID: 13773255
    [No Abstract]   [Full Text] [Related]  

  • 14. A HYPOTHESIS CONCERNING A SITE OF ACTION OF TRANQUILIZING DRUGS AND THE SIGNIFICANCE OF ASSOCIATED EXTRAPYRAMIDAL MOTOR PHENOMENA.
    VENNING GR
    J New Drugs; 1963; 3(6):351-5. PubMed ID: 14113558
    [No Abstract]   [Full Text] [Related]  

  • 15. [CLOPENTHIXOL (CIATYL). NEUROLEPTIC EFFECT WITH SPECIAL REFERENCE TO EXTRAPYRAMIDAL SYMPTOMS].
    NOECKER G
    Med Klin; 1964 May; 59():776-9. PubMed ID: 14225431
    [No Abstract]   [Full Text] [Related]  

  • 16. [Extrapyramidal tract diseases].
    KASE M
    Naika; 1962 Dec; 10():1060-2. PubMed ID: 13962660
    [No Abstract]   [Full Text] [Related]  

  • 17. [ELECTROMYOGRAPHIC ANALYSIS OF THE EFFECT OF A SINGLE DOSE OF TRIHEXYPHENIDYL AND IMIPRAMINE ON EXTRAPYRAMIDAL DISORDERS DIAGNOSED IN NEUROLEPTIC THERAPY].
    ZAKRZEWSKA F; SZYMKIEWICZ H; GRABOWSKI K
    Neurol Neurochir Psychiatr Pol; 1963; 13():687-93. PubMed ID: 14091517
    [No Abstract]   [Full Text] [Related]  

  • 18. [Contribution to the study of extrapyramidal syndromes following use of neuroleptics. Apropos of the use of 2 psychotropic substances with powerful neurotropic activity].
    BORENSTEIN P; DABBAH M; BLES G
    Ann Med Psychol (Paris); 1962 Feb; 120(1)():279-319. PubMed ID: 13871266
    [No Abstract]   [Full Text] [Related]  

  • 19. A parallel between the profile of clinical activity and the character of extrapyramidal activity of neuroleptics.
    CORNMAN HD
    Rev Can Biol; 1961 Jun; 20():575-7. PubMed ID: 13881414
    [No Abstract]   [Full Text] [Related]  

  • 20. The implications of extrapyramidal symptoms in the treatment of schizophrenia.
    DENHAM J
    Rev Can Biol; 1961 Jun; 20():545-8. PubMed ID: 13885426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.